Osimertinib plus chemotherapy improves progression-free survival in EGFR-mutated non-small cell lung cancer

Updated on: September 30,2025 0

Osimertinib plus chemotherapy improves progression-free survival in EGFR-mutated non-small cell lung cancer

Updated on:September 30,2025 0

Key DNA complex connected to polymerase inhibitor cancer-drug resistance discovered

Updated on: July 14,2025 0

Key DNA complex connected to polymerase inhibitor cancer-drug resistance discovered

Updated on:July 14,2025 0

Some lung cancer patients may experience durable disease control even after discontinuing immunotherapy

Updated on: May 19,2025 0

Some lung cancer patients may experience durable disease control even after discontinuing immunotherapy

Updated on:May 19,2025 0

Recommendations developed for young adult cancer survivor follow-up care

Updated on: October 06,2025 0

Recommendations developed for young adult cancer survivor follow-up care

Updated on:October 06,2025 0

Cancer diagnosis does not spur improvements to survivors' diets or eating habits

Updated on: August 13,2025 0

Cancer diagnosis does not spur improvements to survivors' diets or eating habits

Updated on:August 13,2025 0

Cancer before 40: Eexpert shares 3 topics that younger patients often want to discuss

Updated on: July 11,2025 0

Cancer before 40: Eexpert shares 3 topics that younger patients often want to discuss

Updated on:July 11,2025 0

New research identifies IFITM3 as key driver of immunotherapy response in small cell lung cancer

Updated on: October 02,2025 0

New research identifies IFITM3 as key driver of immunotherapy response in small cell lung cancer

Updated on:October 02,2025 0

Circulating tumor DNA may guide immunotherapy use in limited-stage SCLC, new study shows

Updated on: October 04,2025 0

Circulating tumor DNA may guide immunotherapy use in limited-stage SCLC, new study shows

Updated on:October 04,2025 0

Novel immunotherapy strategy shows promising long-term survival in certain advanced NSCLC patients

Updated on: October 06,2025 0

Novel immunotherapy strategy shows promising long-term survival in certain advanced NSCLC patients

Updated on:October 06,2025 0

Researchers challenge FDA warning on common epilepsy drug

Updated on: July 09,2025 0

Researchers challenge FDA warning on common epilepsy drug

Updated on:July 09,2025 0